Philips to focus on medication adherence monitoring
09 October 2018 | News
Royal Philips has signed a Memorandum of Understanding (MoU) with Ypsomed, a self-medication systems maker.
Image credit- futureconsumer.com
Royal Philips has signed a Memorandum of Understanding (MoU) with Ypsomed, a self-medication systems maker, to co-develop and deploy new digital services for the monitoring of medication adherence.
The new SmartServices will be backed by Philips’ Cloud-based HealthSuite digital platform, which offers tools and services for easy integration, management and end-to-end security.
SmartServices will comprise a set of digital services to address device-related challenges and support self-medication for patients with chronic diseases such as diabetes and rheumatoid arthritis.
The deal will facilitate the integration of Ypsomed’s smart medical devices into Philips HealthSuite digital platform thereby improving therapy-specific care pathways.
